Document is current
Any future updates will be listed below
-
Authors
Luessen, Deborah J. https://orcid.org/0000-0003-0624-8624
Gallinger, Isabel M.
Ferranti, Anthony S.
Foster, Daniel J. https://orcid.org/0000-0002-5225-354X
Melancon, Bruce J.
Lindsley, Craig W.
Niswender, Colleen M.
Conn, P. Jeffrey
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH065215, MH119673, MH062646)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS031373)
- License Information
-
More Information
Article History
Received: 3 February 2022
Revised: 12 May 2022
Accepted: 20 May 2022
First Online: 28 May 2022
Change Date: 14 July 2023
Change Type: Update
Change Details: The author P. Jeffrey Conn was tagged incorrectly in the HTML version of the original article.
Competing interests
: PJC, CWL, and CMN receive research support from Boehringer Ingelheim and Acadia Pharmaceuticals. CWL also receives support from Ono Pharmaceutical. PJC, CWL, and CMN are inventors on multiple patents for allosteric modulators of metabotropic glutamate receptors. All other authors declare no potential conflicts of interest.
